Read the full interview of Ali Pashazadeh, Treehill Partners CEO at Genetic Engineering & Biotechnology News (GEN) – a renown publication where GEN’s unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research , bioprocessing, and commercialization.
The interview covers key considerations on data-led decision making in the boarder healthcare industry, approaches to steer and execute healthcare policy, and the continued unmet need for improved efficiency in the ecosystem of pharmaceutical innovation, validation, commercialisation, and patient benefit.